Pencil Beam Scanning Proton Therapy

RADIATION3 trials

Sponsors

NRG Oncology, The New York Proton Center, Thompson Cancer Survival Center

Conditions

Breast CancerBreast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage IIICNS CancerGI CancerGynecologic CancerHead and Neck Cancer

Phase 3

Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma

TerminatedNCT04158141

NRG OncologyPleural Biphasic Mesothelioma, Pleural Epithelioid Mesothelioma, Stage IA Pleural Malignant Mesothelioma AJCC v8 +4

Start: 2020-01-29End: 2023-11-20Updated: 2025-02-19

Unknown Phase

Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors

RecruitingNCT05313191

The New York Proton CenterBreast Cancer, CNS Cancer, GI Cancer +4

Start: 2022-01-24End: 2027-01-31Target: 1800Updated: 2024-12-17

Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy

RecruitingNCT06006806

Thompson Cancer Survival CenterBreast Cancer, Breast Cancer Stage I, Breast Cancer Stage II +1

Start: 2023-07-07End: 2030-07-07Target: 100Updated: 2025-04-08

Related Papers

A phase III randomized trial of pleurectomy/decortication plus chemotherapy with or without adjuvant hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) for malignant pleural mesothelioma (MPM) (NRG LU-006).

Journal of Clinical Oncology2020-05-201 citations